All Blogs / Health / Diseases & Conditions / Cancer / New


Study: A new way to slow cancer cell growth

(University of Rochester Medical Center) Researchers have identified a new way to potentially slow the fast-growing cells that characterize all types of cancer. By removing a specific protein from cells, they were able to slow the cell cycle, which is out of control in cancer. Show More Summary

Study: Many patients with early-stage breast cancer receive costly, inappropriate testing

(Fred Hutchinson Cancer Research Center) A study from Fred Hutchinson Cancer Research Center that will be presented at the American Society of Clinical Oncology annual meeting on June 5 in Chicago shows that asymptomatic women who have...Show More Summary

Genetic risk factor for equine eye cancer identified

(University of California - Davis) UC Davis researchers have identified a genetic mutation in horses that should help identify horses that are at risk for squamous cell carcinoma of the eye and enable horse owners to make informed breeding decisions.

Brain microenvironment makes HER2-positive breast cancer metastases resistant to treatment

(Massachusetts General Hospital) A Massachusetts General Hospital-based research team has identified a novel mechanism behind the resistance of breast cancer brain metastases to HER2- or PI3K-targeted therapies and a treatment strategy that may overcome this resistance.

BU researcher receives entrepreneur award from the American Thoracic Society

(Boston University Medical Center) Avrum Spira, MD, MSc, professor of medicine, pathology and bioinformatics at Boston University School of Medicine (BUSM), is the inaugural recipient of the Research Innovation and Translation Achievement Award from the American Thoracic Society (ATS).

Where body fat is carried can predict cancer risk

(Cancer Research UK) Scientists have found that carrying fat around your middle could be as good an indicator of cancer risk as body mass index (BMI), according to research published in the British Journal of Cancer today.

Raised blood platelet levels 'strong predictor' of cancer

(University of Exeter) Having a high blood platelet count is a strong predictor of cancer and should be urgently investigated to save lives, according to a large-scale study.

New insight into life-threatening childhood brain cancer

(Newcastle University) The most common type of malignant childhood brain cancer has been identified as seven separate conditions each needing a different treatment, new research has revealed.

Black persons more likely than whites to be diagnosed with colon cancer, despite screening

(American College of Physicians) A study of elderly Medicare enrollees found that black persons face a 31 percent greater risk than white persons for interval colorectal cancer (CRC), or cancer that develops after a negative result on a colonoscopy but before the next recommended screening. Show More Summary

Taking a closer look at genetic switches in cancer

(California Institute of Technology) Caltech biochemists have uncovered details of a protein that controls blood cell production in an aggressive form of leukemia.

New cancer drug can prevent reactions to common airborne allergens

(Northwestern University) A cancer drug for patients with certain types of leukemia and lymphoma can also prevent reactions to some of the most common airborne allergies, according to a recent Northwestern Medicine study. The promising data from this pilot study could have greater implications for adults with food allergies.

CNIO researcher funded by Melanoma Research Alliance to study brain metastasis in melanoma

(Centro Nacional de Investigaciones Oncológicas (CNIO)) Manuel Valiente, head of the Brain Metastasis Group at the Spanish National Cancer Research Centre (CNIO), has been funded in the 2017 grant cycle by the Melanoma Research Alliance (MRA), the largest private funder of melanoma research. Show More Summary

Flexible new method for early cancer diagnosis

(University of Gothenburg) Earlier discovery of cancer and greater precision in the treatment process are the objectives of a new method developed by researchers at Sahlgrenska Academy and Boston University. Investments are now being made to roll out this innovation across healthcare and broaden the scope of the research in this field.

Doctors urge FDA to tighten regulations on 'filtered' cigarettes

(MediaSource) While the overall rate of lung cancer continues to decline in the United States, one form of the disease often found in the outer areas of the lungs continues to climb -- and experts think they know why.

Antibody for fighting cancer emerges

(Brigham and Women's Hospital) While studying the underpinnings of multiple sclerosis, investigators at Brigham and Women's Hospital came across important clues for how to treat a very different disease: cancer. Researchers describeShow More Summary

One in 5 cancers diagnosed in the United States is a rare cancer

(American Cancer Society) About one in five cancer diagnoses in the United States is a rare cancer, according to a new American Cancer Society report.

More cancers diagnosed at early stage following increase in health insurance coverage

(American Society of Clinical Oncology) An analysis of nearly 273,000 patients showed that between 2013 and 2014 there was a 1% increase in the percentage of breast, lung, and colorectal cancers diagnosed at the earliest, most treatable stage.

HPV vaccination may reduce oral HPV infections -- but still under-utilized

(American Society of Clinical Oncology) In one of the first large studies to explore the possible impact of HPV vaccination on oral HPV infections, researchers found it may confer a high degree of protection. The study of young adults...Show More Summary

Targeted therapy can delay recurrence of intermediate-stage lung cancer

(American Society of Clinical Oncology) The targeted therapy gefitinib appears more effective in preventing recurrence after lung cancer surgery than the standard of care, chemotherapy.

Oral chemotherapy extends survival by more than a year in biliary tract cancer

(American Society of Clinical Oncology) A phase III randomized clinical trial of 447 patients with biliary tract cancers (BTCs, cancers of the bile duct and gallbladder) showed that giving capecitabine after surgery extends survival by a median of 15 months compared to surgery alone.

Copyright © 2015 Regator, LLC